Benchmark Downgrades PetIQ to Hold From Buy, Price Target Is $30
Benchmark Co. Keeps Their Buy Rating on Petiq (PETQ)
Petiq (PETQ) Was Downgraded to a Hold Rating at Truist Financial
PetIQ Price Target Raised to $31.00/Share From $30.00 by Truist Securities
PetIQ Analyst Ratings
Lake Street Remains a Buy on Petiq (PETQ)
PetIQ Analyst Ratings
Benchmark Reiterates Buy on PetIQ, Maintains $30 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: Petiq (PETQ), Leafly Holdings, Inc. (LFLY) and AMN Healthcare Services (AMN)
Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX), Petiq (PETQ) and Biodesix (BDSX)
Oppenheimer Sticks to Their Hold Rating for Petiq (PETQ)
Oppenheimer Sticks to Its Hold Rating for Petiq (PETQ)
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Amgen (AMGN) and Petiq (PETQ)
PetIQ Analyst Ratings
Jefferies Maintains Buy on PetIQ, Raises Price Target to $28
Petiq (PETQ) Gets a Buy From Lake Street
Oppenheimer Reaffirms Their Hold Rating on Petiq (PETQ)
Jefferies Initiates Coverage On PetIQ With Buy Rating, Announces Price Target of $22
PetIQ Analyst Ratings
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Charlotte's Web Holdings (OtherCWBHF) and Petiq (PETQ)